Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Repros Therapeutics Inc.

  Law Offices of Howard G. Smith Announces Investigation on Behalf of
  Investors of Repros Therapeutics Inc.

Business Wire

BENSALEM, Pa. -- October 24, 2013

Law Offices of Howard G. Smith announces that it is investigating potential
claims on behalf of investors of Repros Therapeutics Inc. (“Repros” or the
“Company”) (NASDAQ:RPRX) concerning possible violations of federal securities
laws. The investigation focuses on certain statements issued by Repros
concerning the Company’s operations and financial prospects.

Repros is a development stage biopharmaceutical company engaged in the
development of new drugs to treat hormonal and reproductive system disorders.
The Company’s product portfolio includes Androxal – an oral therapy for the
treatment of low testosterone due to secondary hypogonadism. Androxal is
currently in Phase III clinical trials.

The investigation is related to the Company’s recent announcement that the
Food and Drug Administration has raised concerns about the reliability of some
of the clinical data collected during Androxal’s Phase III pivotal efficacy
studies, ZA-301 and ZA-302. Previously, in a press release the Company issued
on September 18, 2013, Repros had stated that “the Company is completely
satisfied that all data entered into the data base for study ZA-301 will pass
any scrutiny the FDA chooses to apply.”

On October 22, 2013, Repros disclosed that the FDA has instructed Repros to
request a meeting to discuss the adequacy of studies ZA-301 and ZA-302 as
evidence of pivotal efficacy. In addition, the FDA has instructed Repros to
submit additional study data for Androxal, which will delay the submission of
the Company’s New Drug Application until the third or fourth quarter of 2014.
Following this news, the price of Repros stock dropped more than 27%, or $6.57
per share, to a closing price of $17.12 on October 23, 2013.

If you purchased Repros shares, if you have information or would like to learn
more about these claims, or if you have any questions concerning this
announcement or your rights or interests with respect to these matters, please
contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070
Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, Toll Free at (888) 638-4847, or by email to
howardsmith@howardsmithlaw.com, or visit our website at
www.howardsmithlaw.com.

Contact:

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
(215) 638-4847
(888) 638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
 
Press spacebar to pause and continue. Press esc to stop.